Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
Yuanda Liu, Changfeng Li, Yaoping Lu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
AMPK–a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment?
Na Wang, Bofang Wang, Ewetse Paul Maswikiti, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Training and experimental validation a novel anoikis- and epithelial‒mesenchymal transition-related signature for evaluating prognosis and predicting immunotherapy efficacy in gastric cancer
Cheng Zeng, Chang Xu, Yuhan Wei, et al.
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1078-1100
Open Access | Times Cited: 3
Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers‐Mediated Photodynamic Therapy
Qing Yu, Xia Li, Juan Wang, et al.
Small (2023) Vol. 20, Iss. 16
Closed Access | Times Cited: 23
Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives
Jiahua Liu, Qihang Yuan, Hui Guo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116310-116310
Open Access | Times Cited: 14
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner
Yibing Wang, Peng Jin, Xia Wang
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 142-153
Closed Access | Times Cited: 20
Targeting GPC3 high cancer-associated fibroblasts sensitizing the PD-1 blockage therapy in gastric cancer
Dinuo Li, Yu Wang, Ce Shi, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 19
The emerging role of glycolysis and immune evasion in gastric cancer
Shanshan Zheng, Huai Li, Yaqi Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
TGF-β-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer
Fangbin Zhang, Yan Yan, Xinguang Cao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 7
Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer
Peiyuan Li, Huan Zhang, Tao Chen, et al.
Matrix Biology (2024) Vol. 132, pp. 59-71
Open Access | Times Cited: 7
Unraveling the intricacies of cancer‐associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk
Sana Ahuja, Niti Sureka, Sufian Zaheer
Apmis (2024)
Closed Access | Times Cited: 6
Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets
Xuanbo Da, Bangping Cao, Jiantao Mo, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Identification of crucial genes through WGCNA in the progression of gastric cancer
Rui Liu, Jie Liu, Qiang Cao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3284-3296
Open Access | Times Cited: 5
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)
Yan Liu, Jun Liang, Yanping Zhang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 4
Open Access | Times Cited: 5
A large histological images dataset of gastric cancer with tumour microenvironment annotation for AI
Shenghan Lou, Jianxin Ji, Huiying Li, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
To describe the subsets of malignant epithelial cells in gastric cancer, their developmental trajectories and drug resistance characteristics
Tingting Xu, Tianying Zhang, Yan Sun, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Nanoparticles, a promising treatment for gastric cancer
Hua Dong, Xiexing Wu, Zebin Wu, et al.
Smart Materials in Medicine (2025)
Open Access
Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer
Qiying Song, Shihe Liu, Di Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Identification of Cross-Cancer Biomarkers: COMP mRNA and CARMN/GSEC lncRNAs Shared in Breast, Gastric, and Colorectal Cancers via Integrated Systems Biology and Experimental Validation
M. Aiman Askari, Ali Hodaeian, Saba Hesami, et al.
Research Square (Research Square) (2025)
Open Access
RGS1 can serve as a long-term prognostic marker in gastric cancer by promoting the infiltration and polarization of macrophages
Yuzheng Zhang, Zhifang Jia, Donghui Cao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167711-167711
Closed Access
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 257-257
Open Access
Patient-derived tumor xenograft animal model of gastric cancer in precision chemotherapy
Yiyin Zhang, Yongming Yang, Jiayi Zhou, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top